Ryan Fukushima | Reinventing diagnostics: The superpower of not knowing what can’t be done | TPM #43
Talking Precision Medicine
Transforming Cancer Diagnostics
This chapter examines the evolution of cancer diagnostics over the last decade, highlighting the shift from narrow mutation testing to a broader, data-rich approach. It discusses the challenges and innovations in establishing a market for comprehensive diagnostics, emphasizing the importance of patient data and collaborative efforts in improving treatment options. The role of RNA and its integration into clinical practices is explored, showcasing its impact on personalized medicine and drug development strategies.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
